Accumulating evidence shows that PKM2 activity is closely related to the occurrence and development of tumors, with PKM2 activity being more conducive to the increased needs of tumor cells for the glycolytic intermediates required to promote tumor proliferation and invasion and maintain the malignant phenotype of tumor [13,14]. This evidence concerns the gene PKM and neoplasm.